Actinogen Medical Limited

DB:3AC Stock Report

Market Cap: €44.3m

Actinogen Medical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:3AC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Dec 24Sell€287,722BVF Partners L.P.Company19,000,000€0.015
04 Nov 24Buy€30,291George MorstynIndividual1,666,668€0.018
04 Nov 24Buy€30,291Geoffrey Edward BrookeIndividual1,666,668€0.018
04 Nov 24Buy€605,812Steven GourlayIndividual33,333,334€0.018
04 Nov 24Buy€18,174Malcolm McComasIndividual1,000,000€0.018
05 Jun 24Buy€73,321Steven GourlayIndividual4,800,000€0.015
05 Jun 24Buy€5,601Nicki VasquezIndividual366,667€0.015
05 Jun 24Buy€11,432George MorstynIndividual748,425€0.015
05 Jun 24Buy€18,001Geoffrey Edward BrookeIndividual1,178,463€0.015
05 Jun 24Buy€6,847Malcolm McComasIndividual448,241€0.015

Insider Trading Volume

Insider Buying: 3AC insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 3AC?
Owner TypeNumber of SharesOwnership Percentage
Institutions83,159,4592.71%
Private Companies144,667,3824.71%
Hedge Funds228,334,6807.43%
Individual Insiders389,900,92512.7%
General Public2,227,251,34972.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.2%.

Top Shareholders

Top 25 shareholders own 27.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.43%
BVF Partners L.P.
228,334,680€3.3m-7.68%0.12%
4.23%
Steven Gourlay
129,928,148€1.9m34.5%no data
1.72%
Jsc Wealth Management Pty Ltd
52,966,360€762.7k18.6%no data
1.57%
Old College Capital Holdings Limited
48,147,864€693.3k0%no data
1.16%
Sarah Cameron
35,600,000€512.6k0%no data
1.14%
Precision Funds Management Pty Ltd
35,000,000€504.0k0%1.21%
1.02%
Garnsworthy Pension Fund PTY Ltd
31,500,000€453.6k43.2%no data
1.02%
Thomas Henderson
31,403,330€452.2k6.67%no data
0.91%
Simon Joyner
28,100,000€404.6k170%no data
0.86%
John Ketelbey
26,483,275€381.4k30.2%no data
0.79%
Martin Rogers
24,347,335€350.6k0%no data
0.69%
Sve Capital Pty Ltd
21,146,116€304.5k98.7%no data
0.67%
Geoffrey Edward Brooke
20,522,072€295.5k8.84%no data
0.64%
Peter Kyros Pty Ltd
19,530,676€281.2k0%no data
0.64%
Iral Pty Ltd
19,524,230€281.1k30.2%no data
0.44%
George Morstyn
13,643,463€196.5k13.9%no data
0.39%
James Murch
11,985,689€172.6k16.9%no data
0.39%
Catherine Murch
11,985,689€172.6k16.9%no data
0.36%
Guillermo Orselli
10,981,711€158.1k0%no data
0.36%
David Krelle
10,981,710€158.1k0%no data
0.32%
Ronald Nes
9,750,000€140.4k30%no data
0.32%
Gillian Nes
9,750,000€140.4k30%no data
0.27%
Malcolm McComas
8,171,836€117.7k13.9%no data
0.19%
Nicki Vasquez
5,866,667€84.5k0%no data
0.013%
William Souter
400,000€5.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 01:20
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Actinogen Medical Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tara SperanzaBell Potter
Pooya HemamiEdison Investment Research